SCIENTIFIC-PRACTICAL JOURNAL

| укр | рус |

 

 
Home Editorial ethics For authors Current issue Archive Contacts

No3(3) 2020

Back to the issue


DOI 10.37219/2528-8253-2020-3-18
Kizim Ya.V.
Screening and diagnosis of laryngopharyngeal reflux in patients with laryngeal cancer stage I-II (T1-2N0M0)
Kizim Yaroslav V.
State Institution “Institute of otolaryngology named after Prof. O.S. Kolomiychenko of the National Academy of Medical Sciences of Ukraine”; Kyiv, Ukraine.
Department of Clinical Allergology
Junior Researcher
E-mail: 90kizim@gmail.com
https://orcid.org/0000-0001-5062-7707

Abstract

Topicality: The variety of manifestations of laryngopharyngeal reflux (LPR) in otolaryngological practice has made this problem relevant for the past decades. The development of LPR is associated with impaired function of the upper esophageal sphincter, which allows reflux to enter the larynx, pharynx, nasal cavity and middle ear cavity. In a number of studies, pathological reflux has been identified as one of the factors in the development of cancer of the upper respiratory and digestive tract.
Aim of the study: to improve methods fors creening and diagnosis of laryngopharyngeal reflux in patients with laryngeal cancer stage I-II (T1-2N0M0).
Materials and methods: The study group included 93 patients with stage I-II laryngeal cancer (T1-2N0M0).
The control group was represented by 36 patients with reflux-associated benign neoplasms of the larynx. For preliminary diagnosis and objectification of complaints used the RSI test. To increase the accuracy of interpretation and objectification of laryngoscopic manifestations of LPR, the RFS scale was used. The daily pH-monitoring was carried out using an AG-1pH-M acidogastrograph with an electrode system. The severity of reflux was determined according to DeMeester criteria. According to the results of pH monitoring, clinical groups were formed.
Results: When analyzing the results of the examination, the RSI index exceeded “9” in 41 (44.1%) patients. When tested on the RFS scale, the indicator “13 and higher” was recorded in 48 (51.6%) patients. All patients (41) with a positive RSI test received 24-hour pH monitoring. According to 24-hour pH-monitoring, the presence of LPR was verified in 33 (80.1%) patients with a positive RSI test. The study group consisted of 33 (80.1%) patients with
squamous cell carcinoma of the larynx T1-2N0M0. After 24-hour pH-monitoring, we obtained the data: mild LPR was observed in 6 (18.2%) patients, moderate severity of LPR in 18 (54.5%) and severe LPR in 9 (27.3%). In patients with laryngeal cancer T1-2N0M0, which is associated with LPR, the DeMeester criterion exceeded 14.72.
Conclusions: Comparison of pH-monitoring data and visual-analogue scales reaches 80.1% of compliance in patients with laryngeal cancer T1-2N0M0, which is associated with LPR. According to 24-hour pH-monitoring, the presence of LPR was verified in 33 (35.5%) of the examined patients with squamous cell carcinoma of the larynx. Using the modified The Reflux Symptom Index and The Reflux Finding Score scales is a highly reliable method for screening the diagnosis of laryngopharyngeal reflux in patients with laryngeal cancer.

Keywords

laryngopharyngeal reflux, laryngeal cancer.


Reference

  1. Boenko SK, KizimVV, Yurenko EA. [Clinical and morphological manifestations of laryngopharyngeal reflux]. Archives of clinical and experimental
    medicine. 2011;20(1):37-40. [Article in Russian].
  2. Kizim VV, Yurenko EA. [Analysis of the clinical manifestations of laryngopharyngeal reflux based on the RSI test]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2012;5(с):68-69.[Article in Russian].
  3. Kizim VV, Yurenko EA, Boenko SK. [Using the RSI and RFS tests in the diagnosis of laryngopharyngeal reflux]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2013;3(с):35-36.[Article in Russian].
  4. Kizim VV, Boenko SK, Yurenko EA, Koshyk EA. [The role of biomarkers in the diagnosis of laryngopharyngeal reflux]. Zhurnal ushnyh, nosovyh
    i gorlovyh boleznej. 2012;3(с):95-96.[Article in Russian].
  5. Pohosova TG, Zaviktorina YL, Soldatskiy IE. [Gastroesophageal and pharyngolaryngeal reflux]. Vestn Otorinolaringol. 2007;5:83-87. [Article in Russian].
  6. Ahuja V, Yencha MW, Lassen LF. Head and neck manifestation of gastroesophageal reflux disease. Am Fam Physician. 1999 Sep 1;60(3):873-80, 885-6. PMID: 10498113.
  7. Al-Saab F, Manoukian JJ, Al-Sabah B, Almot S, Nguyen LHP, Tewfik TL, et al. Linking laryngopharyngeal reflux to otitis media with effusion: pepsinogen study of adenoid tissue and middle ear fluid. J Otolaryngol Head Neck Surg. 2008 Aug;37(4):565-71.
  8. Barry DW, Vaezi MF. Laryngopharyngeal reflux: more questions than answers. Cleve Clin J Med. 2010 May;77(5):327-34.
    doi: 10.3949/ccjm.77a.09121.
  9. Belafsky PC, Postma GN, Amin MR, Koufman JA. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):10-3.
  10. Bulmer DM, Ali MS, Brownlee IA, Dettmar PW, Pearson JP. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010
    Apr;120(4):777-82. doi: 10.1002/lary.20665.
  11. Carroll TL, Gartner-Schmidt J, Statham MM, Rosen CA. Vocal process granuloma and glottal insufficiency: an overlooked etiology? Laryngoscope.
    2010 Jan;120(1):114-20. doi: 10.1002/lary.20656.
  12. Kuo CL. Laryngopharyngeal Reflux: An Update. Archives of Otorhinolaryngology-Head & Neck Surgery. 2019;3(1):1. doi: 10.24983/scitemed.
    aohns.2019.00094. Available from: https://scitemed.com/article/2594/LaryngopharyngealReflux-An-Update.
  13. Chung JH, Tae K, Lee YS. Jeong JH, Cho SH, Kim KR, et al. The significance of laryngopharyngeal reflux in benign vocal mucosal lesions. Otolaryngol Head Neck Surg. 2009 Sep;141(3):369-73. doi: 10.1016/j.otohns.2009.05.033.
  14. Cohen JT, Bach KK, Postma GN, Koufman JA. Clinical manifestations of laryngopharyngeal reflux. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):19-23.
  15. Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF, Mathus-Vliegen LM. High incidence of laryngopharyngeal reflux in patients
    with head and neck cancer. Laryngoscope. 2000 Jun;110(6):1007-11. doi: 10.1097/00005537-200006000-00023.
  16. DeMeester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, et al. Technique, indications, and clinical use of 24 hour esophageal
    pH monitoring. J Thorac Cardiovasc Surg. 1980 May;79(5):656-70.
  17. Galli J, Cammarota G, Calò L, Agostino S, D’Ugo D, Cianci R, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope. 2002 Oct;112(10):1861-5. doi: 10.1097/00005537-200210000-00030.
  18. Glanz H, Kleinsasser O. [Chronic Laryngitis and Carcinoma (Author’s Transl)]. Arch Otorhinolaryngol. 1976 Feb 8;212(1):57-75.
    doi: 10.1007/BF00456363. [Article in German].
  19. Hammer HF. Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist’s point of view. Dig Dis. 2009;27(1):14-7.
    doi: 10.1159/000210098.
  20. Hillel AT, Lin LM, Samlan R, Starmer H, Leahy K, Flint PW, et al. Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process
    granulomas: a series of 67 granulomas. Ann Otol Rhinol Laryngol. 2010 May;119(5):325-30. doi: 10.1177/000348941011900509.
  21. Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope. 2004 Dec;114(12):2129-34. doi: 10.1097/01.mlg.0000149445.07146.03.
  22. Kantas I, Balatsouras DG, Kamargianis N, Katotomichelakis M, Riga M, Danielidis V. The influence of laryngopharyngeal reflux in the healing
    of laryngeal trauma. Eur Arch Otorhinolaryngol. 2009 Feb;266(2):253-9. doi: 10.1007/s00405-008-0744-3.
  23. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;
    108(3):308-28; quiz 329. doi: 10.1038/ajg.2012.444.
  24. Kizim V, Yurenko E, Kizim Y. Biomarkers in diagnosis of laryngopharyngeal reflux. Folia otorhinolaryngologiae et pathologiae respiratoriae.
    2014;20(2):127.
  25. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002 Jul;127(1):32-5.
    doi: 10.1067/mhn.2002.125760.
  26. Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, Al-Jubad A. Effects of simulated gastro-oesophagealrefluxon the untraumatized rabbit
    larynx. J Otolaryngol. 1998 Jun;27(3):127-31.
  27. Olson NR. Aerodigestive Malignancy and Gastroesophageal Reflux Disease. Am J Med. 1997 Nov 24;103(5A):97S-99S.
    doi: 10.1016/s0002-9343(97)00332-x.
  28. Rees L, Pazmany L, Gutowska-Owsiak D, Inman ChF, Phillips A, Stokes ChR, et al. The Mucosal Immune Response to Laryngopharyngeal
    Reflux. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1187-93. doi: 10.1164/rc-cm.200706-895OC.
  29. Reichel O, Mayr D, Durst F, Berghaus A. E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with LPR. Eur Arch Otorhinolaryngol. 2008 Aug;265(8):937-42. doi: 10.1007/s00405-007-0568-6.
  30. Sataloff RT. Gastroesophageal reflux-related chronic laryngitis. Commentary. Arch Otolaryngol Head Neck Surg. 2010 Sep;136(9):914-5.
    doi: 10.1001/archoto.2010.145.
  31. Sereg-Bahar M, Jansa R, Hocevar-Boltezar I. Voice disorders and gastroesophageal reflux. Logoped Phoniatr Vocol. 2005;30(3-4):120-4.
    doi: 10.1080/14015430500320182.
  32. Storck C, Brockmann M, Zimmermann E, Nekahm-Heis D, Zorowka PG. [Laryngeal granuloma. Aetiology, clinical signs, diagnostic procedures, and treatment]. HNO. 2009 Oct;57(10):1075-80. doi: 10.1007/s00106-008-1778-y. [Article in German].
  33. Tsunoda K, Ishimoto S, Suzuki M, Hara M, Yamaguchi H, Sugimoto M, et al. An effective management regimen for laryngeal granuloma caused by gastro-esophageal reflux: combination therapy with suggestions for lifestyle modifications. Acta Otolaryngol. 2007 Jan;127(1):88-92.
    doi: 10.1080/00016480600606665.
  34. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux
    disease: a global evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-20. doi: 10.1111/j.1572-0241.2006.00630.x.
  35. Weldon D. Laryngopharyngeal reflux and chronic sinusitis. Curr Allergy Asthma Rep. 2007 Jun;7(3):197-201. doi: 10.1007/s11882-007-0072-5.
 

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»